EP1858535A4 - Zusammensetzungen mit actinidia und anwendungsverfahren dafür - Google Patents

Zusammensetzungen mit actinidia und anwendungsverfahren dafür

Info

Publication number
EP1858535A4
EP1858535A4 EP06735914A EP06735914A EP1858535A4 EP 1858535 A4 EP1858535 A4 EP 1858535A4 EP 06735914 A EP06735914 A EP 06735914A EP 06735914 A EP06735914 A EP 06735914A EP 1858535 A4 EP1858535 A4 EP 1858535A4
Authority
EP
European Patent Office
Prior art keywords
actinidia
compositions
methods
actinidia compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06735914A
Other languages
English (en)
French (fr)
Other versions
EP1858535A2 (de
Inventor
Julianne Lindemann
George E Stagnitti
Robert H Driver
Mark A Braman
Nancy E Fogg-Johnson
Sunyoung Kim
Mirim Jin
Hyung-Jin Jung
Sung-Seup Shin
Jin-Hwan Oh
Hwa-Jun Lee
Eun-Jin Park
Bongcheol Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EFFICAS, INC.
Pangenomics Co Ltd
Original Assignee
Pangenomics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pangenomics Co Ltd filed Critical Pangenomics Co Ltd
Publication of EP1858535A2 publication Critical patent/EP1858535A2/de
Publication of EP1858535A4 publication Critical patent/EP1858535A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
EP06735914A 2005-02-25 2006-02-24 Zusammensetzungen mit actinidia und anwendungsverfahren dafür Withdrawn EP1858535A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65683905P 2005-02-25 2005-02-25
US65683805P 2005-02-25 2005-02-25
PCT/US2006/006437 WO2006093793A2 (en) 2005-02-25 2006-02-24 Compositions comprising actinidia and methods of use thereof

Publications (2)

Publication Number Publication Date
EP1858535A2 EP1858535A2 (de) 2007-11-28
EP1858535A4 true EP1858535A4 (de) 2012-05-02

Family

ID=36941647

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06735914A Withdrawn EP1858535A4 (de) 2005-02-25 2006-02-24 Zusammensetzungen mit actinidia und anwendungsverfahren dafür

Country Status (8)

Country Link
EP (1) EP1858535A4 (de)
JP (1) JP2008531584A (de)
AU (1) AU2006218875B2 (de)
BR (1) BRPI0608042A2 (de)
MX (1) MX2007010408A (de)
RU (1) RU2423139C2 (de)
TW (1) TWI385007B (de)
WO (1) WO2006093793A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080175888A1 (en) * 2005-02-25 2008-07-24 Julie Lindemann Combination Therapy Comprising Actinidia and Steroids and Uses Thereof
DE102006055210A1 (de) * 2006-11-21 2008-05-29 Ionescu, John G., Dr. Diätisches Lebensmittel mit erhöhter freie Radikale bindender Wirkung
KR101141182B1 (ko) 2009-05-12 2012-05-02 재단법인 제주테크노파크 항염증성 조성물
US9352008B2 (en) 2009-08-12 2016-05-31 Melaleuca, Inc. Dietary supplements and methods for treating pain and inflammation
JP4750202B2 (ja) * 2009-10-16 2011-08-17 株式会社 藍匠 サルナシを用いた健康補助食品の製造方法
ES2634034T5 (es) * 2009-12-29 2020-09-18 Nestle Sa Composiciones nutricionales con copos de fruta que contienen ácido docosahexenoico
JP5688233B2 (ja) * 2010-04-23 2015-03-25 ポーラ化成工業株式会社 Ｔａｒｃ産生抑制剤
JP6179840B2 (ja) * 2011-11-30 2017-08-16 国立大学法人 岡山大学 サルナシ由来の高極性有機溶媒抽出物とその利用
JP6242669B2 (ja) * 2013-11-27 2017-12-06 日本メナード化粧品株式会社 サルナシ抽出物を含有するヒアルロン酸生成促進剤
CN105410588B (zh) * 2015-11-06 2018-05-08 四川兴食尚科技有限公司 一种猕猴桃泡腾片及其制备工艺
WO2019224200A1 (en) * 2018-05-22 2019-11-28 N.V. Nutricia Biomarkers for improving nutrion for infants at risk
KR102932961B1 (ko) * 2023-11-29 2026-03-20 (주)케이에스코리아 아토피 피부염의 개선 또는 치료용 화장료 조성물 및 그 제조방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022914A1 (en) * 2002-06-07 2004-02-05 Allen Ann De Wees Novel sweetener compositions and methods of use
WO2004017982A1 (en) * 2002-08-23 2004-03-04 Pangenomics Co., Ltd Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242814A (en) * 1989-10-10 1993-09-07 Eli Lilly And Company Polyether antibiotic
RU2186569C2 (ru) * 1996-01-23 2002-08-10 Ай-Си-Эн ФАРМАСЬЮТИКАЛЗ Модуляция экспрессии тн1/тн2 цитокинов рибавирином и аналогами рибавирина в активированных т-лимфоцитах
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
DE19758090B4 (de) * 1997-12-18 2008-10-16 Maria Endres Zusammensetzung und deren Verwendung in Kosmetik und Medizin
JP2002302458A (ja) * 2000-12-26 2002-10-18 Takeda Chem Ind Ltd 併用薬
EP1263926B1 (de) * 2001-03-29 2006-05-17 Council of Scientific and Industrial Research Verfahren zur herstellung von fruchtwein aus beeren des himalaya
US6811796B2 (en) * 2002-04-22 2004-11-02 Matsuura Yakugyo Co., Ltd. Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022914A1 (en) * 2002-06-07 2004-02-05 Allen Ann De Wees Novel sweetener compositions and methods of use
WO2004017982A1 (en) * 2002-08-23 2004-03-04 Pangenomics Co., Ltd Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KIM YOO KYUNG ET AL: "Anti-inflammation activity of Actinidia polygama", ARCHIVES OF PHARMACAL RESEARCH, NATL. FISHERIES UNIVERSITY, PUSAN, KR, vol. 26, no. 12, 1 December 2003 (2003-12-01), pages 1061 - 1066, XP002528453, ISSN: 0253-6269, DOI: 10.1007/BF02994759 *

Also Published As

Publication number Publication date
WO2006093793A3 (en) 2006-12-07
JP2008531584A (ja) 2008-08-14
WO2006093793A8 (en) 2008-03-27
TW200716226A (en) 2007-05-01
AU2006218875B2 (en) 2012-08-09
EP1858535A2 (de) 2007-11-28
WO2006093793A2 (en) 2006-09-08
MX2007010408A (es) 2008-03-25
BRPI0608042A2 (pt) 2009-11-03
TWI385007B (zh) 2013-02-11
RU2007135365A (ru) 2009-03-27
AU2006218875A1 (en) 2006-09-08
RU2423139C2 (ru) 2011-07-10

Similar Documents

Publication Publication Date Title
EP1796537A4 (de) Dendrimer-basierte zusammensetzungen und verfahren zu ihrer verwendung
EP1838331A4 (de) Antimikrobielle peptide und anwendungsverfahren
EP1762234A4 (de) Ampk-aktivator
EP1812102A4 (de) Okklusalstent und verwendungsverfahrn dafür
EP1855833A4 (de) Plasmata und verfahren zu ihrer verwendung
EP1913112A4 (de) Stützmittel und verwendungsverfahren
EP1851335A4 (de) Zusammensetzungen und verfahren zur verwendung von standardisierten gemischen
EP1831207A4 (de) Aminopyrimidinverbindungen und anwendungsverfahren
EP1771786A4 (de) Probensimultanverarbeitung
EP1794372A4 (de) Aufpralldämpfungsvorrichtung
EP1718120A4 (de) Anzeigeelement
EP1706791A4 (de) Fotoresistzusammensetzungen und benutzungsprozesse
EP2066817A4 (de) Molekulare schalter und verfahren zu deren verwendung
EP1722797A4 (de) Isochinolin-derivate und anwendungsverfahren dafür
EP1971600A4 (de) Isoxazolderivate und deren verwendung
EP2040541A4 (de) Hilfsstoffe und verwendungsverfahren
EP1874731A4 (de) Chinobenzoxazinanaloga und verfahren zu deren anwendung
EP1735456A4 (de) Polymerische zusammensetzung und damit verbundenes verwendungsverfahren
EP1827464A4 (de) Zusammensetzungen auf zinkbasis und anwendungsverfahren
EP1954685A4 (de) Furoxanverbindungen, zusammensetzungen und anwendungsverfahren
EP1858535A4 (de) Zusammensetzungen mit actinidia und anwendungsverfahren dafür
EP1817055A4 (de) Ovr110-antikörperzusammensetzungen und verwendungsverfahren
EP1701948A4 (de) Assay für entaktogene
EP1812012A4 (de) Protein-tyrosin-phosphatasehemmer und verfahren zu ihrer verwendung
EP1814977A4 (de) Zusammensetzungen auf arthrospira-basis und verwendungen davon

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070924

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: EFFICAS, INC.

Owner name: PANGENOMICS CO., LTD.

R17D Deferred search report published (corrected)

Effective date: 20080327

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120403

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/00 20060101AFI20120328BHEP

Ipc: A61P 11/06 20060101ALI20120328BHEP

Ipc: A61P 37/08 20060101ALI20120328BHEP

17Q First examination report despatched

Effective date: 20130411

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130903